Communications and Marketing

Ingrid Grummt is "2010 Woman in Science" - DKFZ Researcher Wins 2010 Women in Science Award

No. 04 | 10/02/2010 | by (Sel)

The European Molecular Biology Organization (EMBO) and the Federation of European Biochemical Societies (FEBS) announced Ingrid Grummt from the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) in Heidelberg, Germany, as the winner of the Women in Science Award. Ingrid Grummt has made important contributions to the field of gene regulation throughout her science career. The 2010 FEBS/EMBO Women in Science Award of 10,000 euro will be presented on 30 June at the 35th FEBS Congress in Gothenburg, Sweden.

Prof. Ingrid Grummt

The FEBS/EMBO Women in Science Award, now in its third year, recognizes and rewards an exceptional female researcher in molecular biology. Winners of the award are role models who inspire future generations of women in science.

“Ingrid Grummt is an outstanding scientist who has made seminal contributions in the field of regulation of gene activity throughout her career. This includes her very recent discoveries that link processes in ageing and in some inherited diseases with the silencing of genes required for cell growth,” said selection committee member Claudio Sunkel, Director of the Institute of Molecular and Cellular Biology in Porto, Portugal. The award winner is distinguished not only for her scientific contributions but also for her commitment to the development of European science. Grummt is a member of various international advisory boards, panels and scientific committees.

“It is important to me to inspire young women to face personal and professional challenges,” said the award winner, who is married to a professor of biochemistry, is a mother of a daughter and already has two grandchildren. “I am deeply convinced that integrating career and personal goals makes people happier and more productive in the long run!”

Prior to joining DKFZ in 1990, Ingrid Grummt was a post-doctoral fellow at the German Academy of Sciences in Berlin and the Max Planck Institute of Biochemistry in Munich, and led a research group at the University in Würzburg, Germany. She was honored for her research work with several awards including the Gottfried Wilhelm Leibniz Prize. In 2008, Grummt was awarded an ERC Advanced Grant, a generous grant by the European Research Council.

“I am a big fan of Ingrid Grummt,” admitted Otmar Wiestler, Scientific Director of the German Cancer Research Center. “In the first year of her ‘extension’ she is still at the top level of science!” Aged 66, Ingrid Grummt is already entitled to retirement, but she asked the management board for a three-year extension of her employment at DKFZ. In her private life, Ingrid Grummt also likes to be at the top: She just returned from a three-week tour in the Himalayas.

A picture for this press release is available on the Internet at

The German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) with its more than 3,000 employees is the largest biomedical research institute in Germany. At DKFZ, more than 1,000 scientists investigate how cancer develops, identify cancer risk factors and endeavor to find new strategies to prevent people from getting cancer. They develop novel approaches to make tumor diagnosis more precise and treatment of cancer patients more successful. The staff of the Cancer Information Service (KID) offers information about the widespread disease of cancer for patients, their families, and the general public. Jointly with Heidelberg University Hospital, DKFZ has established the National Center for Tumor Diseases (NCT) Heidelberg, where promising approaches from cancer research are translated into the clinic. In the German Consortium for Translational Cancer Research (DKTK), one of six German Centers for Health Research, DKFZ maintains translational centers at seven university partnering sites. Combining excellent university hospitals with high-profile research at a Helmholtz Center is an important contribution to improving the chances of cancer patients. DKFZ is a member of the Helmholtz Association of National Research Centers, with ninety percent of its funding coming from the German Federal Ministry of Education and Research and the remaining ten percent from the State of Baden-Württemberg.


Subscribe to our RSS-Feed.

to top